Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level Hospital in Romania

(1) Background: The endocrine system has become a prominent target to autoimmune damage during treatment with immune checkpoint inhibitors (ICIs) in cancer patients. Real-world data regarding endocrine immune-related adverse events (irAEs) are needed to explore their impact in cancer patients. An an...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Simona Coniac, Mariana Cristina Costache Outas, Edvina-Elena Pirvu, Raluca-Ileana Patru, Estera Gainariu, Ciprian Aldea, Polixenia Georgeta Iorga, Mihaela Ambroci, Horia-Dan Liscu, Andreea-Iuliana Miron, Corin Badiu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2023-05-01
Rangatū:	Diagnostics
Ngā marau:	endocrine immune-related adverse events (irAEs) immune checkpoint inhibitors (ICIs) Romania
Urunga tuihono:	https://www.mdpi.com/2075-4418/13/10/1788
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!